GNPX

Genprex, Inc. GNPX

GNPX
Genprex, Inc. INM
InMed Pharmaceuticals Inc. LIMN
Liminatus Pharma, Inc. Class A Common Stock BDRX
Biodexa Pharmaceuticals Plc CERO
CERo Therapeutics Holdings, Inc. JAGX
Jaguar Health, Inc. GRI
GRI Bio, Inc. BIVI
BioVie Inc. CNSP
CNS Pharmaceuticals, Inc. TOVX
Theriva Biologics, Inc.

Net profit

EBITDA

P/E Ratio

Capitalization

Performance

Periode GNPX INM LIMN BDRX CERO JAGX GRI BIVI CNSP TOVX
6M -83.71 % -47.14 % -96.27 % -65.21 % -98.94 % -59.44 % -73.85 % -87.03 % -32.27 % -52.45 %
YTD -95.86 % -73.02 % -85.11 % -92.17 % -99.93 % -95.98 % -97.63 % -93.99 % -91.21 % -87.64 %
1Y -96.01 % -72.33 % -85.11 % -91.62 % -99.91 % -95.52 % -97.33 % -93.64 % -90.57 % -84.31 %
3Y -99.91 % -95.09 % -85.11 % -99.99 % -100.00 % -99.97 % -100.00 % -99.80 % -99.99 % -98.06 %
5Y -99.98 % -99.92 % -85.11 % -100.00 % -100.00 % -100.00 % -100.00 % -99.92 % -100.00 % -99.77 %
10Y -99.98 % -99.93 % -85.11 % -100.00 % -100.00 % -100.00 % -100.00 % -99.13 % -100.00 % -100.00 %
From the beginning -99.98 % -99.97 % -85.11 % -100.00 % -100.00 % -100.00 % -100.00 % -99.65 % -100.00 % -100.00 %

Dividend